-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Nuvation Bio, Raises Price Target to $8

Benzinga·11/04/2025 12:56:17
Listen to the news
Citizens analyst Silvan Tuerkcan maintains Nuvation Bio (NYSE:NUVB) with a Market Outperform and raises the price target from $6 to $8.